Annual ROE
-60.80%
-10.60%-21.12%
December 31, 2023
Summary
- As of February 7, 2025, STOK annual return on equity is -60.80%, with the most recent change of -10.60% (-21.12%) on December 31, 2023.
- During the last 3 years, STOK annual ROE has fallen by -42.54% (-232.97%).
- STOK annual ROE is now -114.13% below its all-time high of 430.19%, reached on December 31, 2017.
Performance
STOK ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-55.64%
+1.53%+2.68%
September 30, 2024
Summary
- As of February 7, 2025, STOK quarterly return on equity is -55.64%, with the most recent change of +1.53% (+2.68%) on September 30, 2024.
- Over the past year, STOK quarterly ROE has dropped by -2.12% (-3.96%).
- STOK quarterly ROE is now -366.78% below its all-time high of -11.92%, reached on December 31, 2018.
Performance
STOK Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
STOK ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.1% | -4.0% |
| 3 y3 years | -233.0% | -4.0% |
| 5 y5 years | -410.1% | -4.0% |
STOK ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -54.3% | at low | -59.3% | +10.1% |
| 5 y | 5-year | -322.2% | at low | -243.9% | +10.1% |
| alltime | all time | -114.1% | at low | -366.8% | +10.1% |
Stoke Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -55.64%(-2.7%) |
| Jun 2024 | - | -57.17%(-7.6%) |
| Mar 2024 | - | -61.88%(+8.9%) |
| Dec 2023 | -60.80%(+21.1%) | -56.81%(+6.1%) |
| Sep 2023 | - | -53.52%(+3.7%) |
| Jun 2023 | - | -51.59%(+11.3%) |
| Mar 2023 | - | -46.37%(-1.7%) |
| Dec 2022 | -50.20%(+27.4%) | -47.18%(+4.7%) |
| Sep 2022 | - | -45.07%(+7.5%) |
| Jun 2022 | - | -41.91%(+6.3%) |
| Mar 2022 | - | -39.42%(+12.9%) |
| Dec 2021 | -39.40% | -34.92%(+20.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | -28.89%(+8.4%) |
| Jun 2021 | - | -26.64%(+9.6%) |
| Mar 2021 | - | -24.31%(+4.3%) |
| Dec 2020 | -18.26%(+26.8%) | -23.31%(+1.7%) |
| Sep 2020 | - | -22.93%(+17.4%) |
| Jun 2020 | - | -19.53%(+18.7%) |
| Mar 2020 | - | -16.46%(+1.7%) |
| Dec 2019 | -14.40%(+20.8%) | -16.18%(+4.0%) |
| Sep 2019 | - | -15.56%(+9.3%) |
| Jun 2019 | - | -14.23%(-11.0%) |
| Mar 2019 | - | -15.98%(+34.1%) |
| Dec 2018 | -11.92%(-102.8%) | -11.92% |
| Dec 2017 | 430.19% | - |
FAQ
- What is Stoke Therapeutics annual return on equity?
- What is the all time high annual ROE for Stoke Therapeutics?
- What is Stoke Therapeutics annual ROE year-on-year change?
- What is Stoke Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Stoke Therapeutics?
- What is Stoke Therapeutics quarterly ROE year-on-year change?
What is Stoke Therapeutics annual return on equity?
The current annual ROE of STOK is -60.80%
What is the all time high annual ROE for Stoke Therapeutics?
Stoke Therapeutics all-time high annual return on equity is 430.19%
What is Stoke Therapeutics annual ROE year-on-year change?
Over the past year, STOK annual return on equity has changed by -10.60% (-21.12%)
What is Stoke Therapeutics quarterly return on equity?
The current quarterly ROE of STOK is -55.64%
What is the all time high quarterly ROE for Stoke Therapeutics?
Stoke Therapeutics all-time high quarterly return on equity is -11.92%
What is Stoke Therapeutics quarterly ROE year-on-year change?
Over the past year, STOK quarterly return on equity has changed by -2.12% (-3.96%)